Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for healing after arthroscopic repair of chronic rotator cuff tears
2022-001750-29Phase 2Active
- Sponsor
- AUVA Trauma Center Vienna
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of zoledronic acid in rotator cuff tear, sponsored by AUVA Trauma Center Vienna. Primary endpoints: Tendon integrity at 6 months, Tendon integrity at 12 months and 2 more. Started Jun 2022; status: active.
02
Drugs
zoledronic acid
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on 2022-001750-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001750-29.